File(s) not publicly available

Reason: Under embargo until October 2020. After this date a copy can be supplied under Section 51(2) of the Australian Copyright Act 1968 by submitting a document delivery request through your library, or by emailing document.delivery@monash.edu

The Diagnostic and Therapeutic Development of Molecular Agents for Inflammation and Thrombosis

thesis
posted on 15.10.2019 by EE FANG YU
Inflammation is the body’s physiological response to minimise deleterious impact of injury or infection. However, uncontrolled inflammatory processes can be detrimental and contribute to inflammatory diseases. Inflammatory pathways also cross-talk with coagulation pathways and can increase the risk of thrombosis. As such, inflammation and thrombosis remain to be a major cause of morbidity and mortality, despite much improvement in the understanding of these diseases and drug development over the last 3 decades. My PhD project aims to develop safe and effective molecular agents that target different components of inflammatory and coagulation pathways for diagnostic and therapeutic purposes.

History

Principal supervisor

Karlheinz Peter

Year of Award

2019

Department, School or Centre

Central Clinical School

Course

Doctor of Philosophy

Degree Type

DOCTORATE

Faculty

Faculty of Medicine, Nursing and Health Sciences

Exports

Categories

Exports